Cyanocobalamin

Cyanocobalamin

250px
250px
Identifiers
CAS Number	68-19-9 Y
ChEMBL	ChEMBL1200658 N
DrugBank	DB00115 Y
EC Number	200-680-0 V09XX01 (57Co) V09XX02 (58Co)
UNII	P6YC3EG204 Y
Properties
Chemical formula	C63H88CoN14O14P
Molar mass	1355.38 g/mol
Appearance	Dark red solid
Melting point	> 300 °C
Boiling point	> 300 °C
Solubility in water	Soluble
Pharmacology
ATC code	B03BA01
Vapor pressure	{{{value}}}
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YN ?)
Infobox references

Cyanocobalamin is a synthetic form of vitamin B₁₂. Vitamin B₁₂ is the "generic descriptor" name for any of such vitamers of vitamin B₁₂. Because humans and animals can convert cyanocobalamin to any one of the active vitamin B₁₂ compounds, by definition this makes cyanocobalamin itself a form (or vitamer) of B₁₂.

Chemical properties

Cyanocobalamin is one of the most widely manufactured vitamers in the vitamin B₁₂ family (the family of chemicals that function as B₁₂ when put into the body), because cyanocobalamin is the most air-stable of the B₁₂ forms. It is the easiest to crystallize and, therefore, easiest to purify after it is produced by bacterial fermentation, or synthesized in vitro. It can be obtained as dark red crystals or as an amorphous red powder. Cyanocobalamin is very hygroscopic in the anhydrous form, and sparingly soluble in water (1:80). It is stable to autoclaving for short periods at 121 °C (250 °F). The vitamin B₁₂ coenzymes are very unstable in light. After consumption the cyanide ligand is replaced by other groups (adenosyl, methyl), which are the biologically active forms. The cyanide is excreted.

Chemical reactions

In the cobalamins, cobalt normally exists in the trivalent state, Co(III). However, under reducing conditions, the cobalt center is reduced to Co(II) or even Co(I), which are usually denoted as B_12r and B_12s, for reduced and super reduced, respectively.

B_12r and B_12s can be prepared from cyanocobalamin by controlled potential reduction, or chemical reduction using sodium borohydride in alkaline solution, zinc in acetic acid, or by the action of thiols. Both B_12r and B_12s are stable indefinitely under oxygen-free conditions. B_12r appears orange-brown in solution, while B_12s appears bluish-green under natural daylight, and purple under artificial light.

B_12s is one of the most nucleophilic species known in aqueous solution. This property allows the convenient preparation of cobalamin analogs with different substituents, via nucleophilic attack on alkyl halides and vinyl halides.

For example, cyanocobalamin can be converted to its analog cobalamins via reduction to B_12s, followed by the addition of the corresponding alkyl halides, acyl halides, alkene or alkyne. Steric hindrance is the major limiting factor in the synthesis of the B₁₂ coenzyme analogs. For example, no reaction occurs between neopentyl chloride and B_12s, whereas the secondary alkyl halide analogs are too unstable to be isolated. This effect may be due to the strong coordination between benzimidazole and the central cobalt atom, pulling it down into the plane of corrin ring. The trans effect also determines the polarizability of the Co-C bond so formed. However, once the benzimidazole is detached from cobalt by quaternization with methyl iodide, it is replaced by H₂O or hydroxyl ions. Various secondary alkyl halides are then readily attacked by the modified B_12s to give the corresponding stable cobalamin analogs. The products are usually extracted and purified by phenol-methylene chloride extraction or by column chromatography.

Cobalamin analogs prepared by this method include the naturally occurring coenzymes methylcobalamin and cobamamide, and also other cobalamins which do not occur naturally, such as vinylcobalamin, carboxymethylcobalamin and cyclohexylcobalamin. This reaction is currently being experimented with for use as a catalyst for chemical dehalogenation, organic reagent and photosensitized catalyst system.

Reduced forms of Cyanocobalamin, with a Co(I) (upper) center, Co(II) (middle) center, and Co(III) (lower) center

Production

Cyanocobalamin is commercially prepared by bacterial fermentation. Fermentation by a variety of microorganisms yields a mixture of methyl-, hydroxo-, and adenosylcobalamin. These compounds are converted to cyanocobalamin by addition of potassium cyanide in the presence of sodium nitrite and heat. Since a number of species of Propionibacterium produce no exotoxins or endotoxins and have been granted GRAS status (generally regarded as safe) by the Food and Drug Administration of the United States, they are currently the preferred bacterial fermentation organisms for vitamin B₁₂ production.

Historically, a form of vitamin B₁₂ called hydroxocobalamin is often produced by bacteria, and was then changed to cyanocobalamin in the process of being purified in activated charcoal columns after being separated from the bacterial cultures. This change was not immediately realized when vitamin B₁₂ was first being extracted for characterization. Cyanide is naturally present in activated charcoal, and hydroxocobalamin, which has great affinity for cyanide, picks it up, and is changed to cyanocobalamin. Cyanocobalamin is the form in most pharmaceutical preparations because adding cyanide stabilizes the molecule.

France accounts for 80% of world production, and more than 10 tonnes/year of this compound is sold; 55% of sales is destined for animal feed, while the remaining 45% is for human consumption.

Pharmaceutical use

Cyanocobalamin is usually prescribed after surgical removal of part or all of the stomach or intestine to ensure adequate levels of vitamin B₁₂ in the bloodstream. It is also used to treat pernicious anemia, vitamin B₁₂ deficiency (due to low intake from food), thyrotoxicosis, hemorrhage, malignancy, liver disease and kidney disease. Cyanocobalamin injections are often prescribed to gastric bypass patients having had part of their small intestine bypassed, making it difficult for B₁₂ to be absorbed via food or vitamins. Cyanocobamide is also used to perform the Schilling test to check a person's ability to absorb vitamin B₁₂.

End product of cyanide poisoning treatment

In cases of cyanide poisoning the patient is given hydroxocobalamin, which is a precursor to cyanocobalamin. The hydroxocobalamin binds with the cyanide ion and forms cyanocobalamin, which can then be excreted by the kidneys. This has been used for many years in France and was approved by the U.S. FDA in Dec 2006, marked under the name Cyanokit. The apparent paradox here is that hydroxocobalamin is given in large doses to bind to cyanide in situations of cyanide exposure (most commonly in smoke from a building fire), creating cyanocobalamin which is then excreted in urine, yet cyanocobalamin can be consumed as a pre-vitamin, releasing cyanide when converted to the bioactive forms methylcobalamin and adenosylcobalamin. The answer pertains to amount. With consumption of large amounts of cyanocobalamin, little is converted, the rest either not absorbed at all, or absorbed and excreted in urine unchanged.

Possible side effects

The oral use of cyanocobalamin may lead to skin problems or immunological reactions such as itching and anaphylactic shock. Possible side effects of cyanocobalamin injection include several allergic reactions such as hives, difficult breathing; redness of the face; swelling of the arms, hands, feet, ankles or lower legs; extreme thirst; diarrhea. Less-serious side effects may include headache, dizziness, leg pain, itching, or rash.

In the treatment of megaloblastic anemia with concurrent vitamin B₁₂ deficiency using B₁₂ vitamers (including cyanocobalamin), there is a possibility that patients could develop hypokalemia due to increased erythropoiesis (red blood cell production) and consequent cellular uptake of potassium upon anemia resolution. When treated with vitamin B₁₂, patients with Leber's disease may suffer serious optic atrophy, possibly leading to blindness.

Vitamin B12 metabolism

The two bioactive forms of vitamin B_12r are methylcobalamin in the cytosol and adenosylcobalamin in mitochondria. Multivitamins often contain cyanocobalamin, which is presumably converted to bioactive forms in the body. Both methylcobalamin and adenosylcobalamin are commercially available as supplement pills. The MMACHC gene product catalyzes the decyanation of cyanocobalamin as well as the dealkylation of alkylcobalamins including methylcobalamin and adenosylcobalamin. This function has also been attributed to cobalamin reductases. The MMACHC gene product and cobalamin reductases enable the interconversion of cyano- and alkylcobalamins.

B12 cyanocobalamin is added to fortify nutrition, like baby milk powder, breakfast cereals and energy drinks for humans, also animal feed for poultry and swine and fish feed. Vitamin B₁₂ becomes inactive due to Hydrogen cyanide HCN and Nitric oxide NO in cigarette smoke. Vitamin B₁₂ becomes inactive due to Nitrous oxide N₂O commonly known as laughing gas, used for anaesthesia and as party drug. Vitamin B₁₂ becomes inactive due to microwave or other forms of heating. This all leads to vitamin B12 deficiency and serious diseases, especially for babies and elderly people.

Vitamin B12 is the catalyst of Carbon biochemistry (Methionine cycle, SAMe, DNA, proteins and PEMT) – the Cobalt ion coordinates C as in MUT enzyme molecule (PDB 4REQ).

In the Cytosol

B12 methylcobalamin and 5-methyltetrahydrofolate are needed by Methionine synthase in the Methionine cycle to transfer a methyl group from 5-methyltetrahydrofolate to homocysteine, thereby generating tetrahydrofolate (THF) and methionine, which is used to make SAMe.

SAMe is the universal methyl donor and is used for DNA methylation and to make phospholipid membranes, choline, sphingomyelin, and acetylcholine and other neurotransmitters. Methionine is also the start codon (AUG) in the genetic code, and so protein biosynthesis begins with methionine.

B12 is needed to prevent cancer and autoimmune diseases, since DNA methylation regulates genes and cellular differentiation.

B12 is needed for the prevention of Alzheimer, since synthesis of choline, sphingomyelin membranes, and acetylcholine and other neurotransmitters depend on B12.

THF is needed for DNA synthesis so reduced availability of THF results in ineffective production of cells with rapid turnover, in particular red blood cells. B12 is needed to prevent megaloblastic anemia and pernicious anemia, since making THF needed for DNA synthesis depends on B12, but sufficient supply of folate in the diet can hide this effect of B12 deficiency, since folate can be converted to THF.

This part of biochemistry in the cytosol needs adequate supply of vitamin B12 methylcobalamin, folate, choline and Magnesium - ATP.

In the Transsulfuration pathway, homocysteine is converted first into cystathionine and then into cysteine and propionyl-CoA. The metabolism of propionyl-CoA occurs in the mitochondria and requires B12 adenosylcobalamin to make succinyl-CoA. When the conversion of propionyl-CoA to succinyl-CoA in the mitochondria fails due to vitamin B12 deficiency, then elevated blood levels of methylmalonic acid MMA occur. So elevated blood levels of homocysteine and methylmalonic acid MMA are both indicators of vitamin B12 deficiency.

LDL cholesterol is a lipoprotein used by cells to produce in mitochondria ATP energy molecules. Statins can produce muscle pains. LDL is not a type of cholesterol, but rather can be viewed as a container that transports fats, cholesterol, vitamin D, and fat-soluble anti-oxidants to all the tissues of the body.

In Mitochondria

Vitamin B12 Adenosylcobalamin in Mitochondrion—cholesterol and protein metabolism

B₁₂ adenosylcobalamin is needed as cofactor in Methylmalonyl-CoA mutase—MUT enzyme. Processing of cholesterol and protein gives propionyl-CoA that is converted to methylmalonyl-CoA, which is used by MUT enzyme to make succinyl-CoA. Succinyl-CoA is needed to make heme for hemoglobin and it is used in the citric acid cycle to make ATP chemical energy molecules. Magnesium - ATP is used in the cytosol to power the sodium-potassium pump used to maintain the membrane potential. Failure in maintaining the membrane resting potential leads to apoptosis and the cell will die. Magnesium - ATP is also used for muscle contraction and to power the calcium pump. The sarcoplasmic reticulum contains large stores of calcium, which it sequesters and then releases when the muscle cell is stimulated. When the Calcium pump fails to pump calcium back into the sarcoplasmic reticulum, then overload of calcium ions in the cytosol will give crystallization (calcium carbonate and phosphate) and the cell will die.

B₁₂ is needed to prevent cardiovascular disease, since processing cholesterol depends on B₁₂ and making ATP needed for the sodium and calcium ion pumps depends partly on B₁₂.

B₁₂ is needed to prevent anemia, since making porphyrin and heme in mitochondria for producing hemoglobin in red blood cells depends on succinyl-CoA made by B₁₂.

This part of biochemistry in the mitochondria needs adequate supply of vitamin B₁₂ adenosylcobalamin, biotin, iron and magnesium ions.

Bad absorption of B₁₂ is possibly related with coeliac disease. Intestinal absorption of vitamin B12 requires successively three different protein molecules: Haptocorrin, Intrinsic Factor and Transcobalamin II. The structure of these proteins is available in the Protein Data Bank PDB. You can use the Simple Viewer and then Shift+Mouse = Zoom and Ctrl+Mouse = Move to study these protein structures. Haptocorrin (PDB 4KKI) - Intrinsic Factor (PDB 3KQ4) - Transcobalamin II (PDB 2BB5).

The enzymes that use B₁₂ as a built-in cofactor are Methylmalonyl-CoA mutase (PDB 4REQ) and Methionine synthase (PDB 1Q8J).

See also

• Vitamin B12
• Vitamin B12 deficiency
• Methylcobalamin
• Adenosylcobalamin
• Hydroxocobalamin